ArticleSubstance abuse treatment, prevention, and policy2025
Correlates of residential detoxification completers and non-completers in Alberta.
Article in Substance abuse treatment, prevention, and policy, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
- Factors associated with readmission to residential treatment among clients transitioned from detoxification services in Alberta, Canada.The American journal on addictions · 2026Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
4 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
objectivesWe aimed to identify factors correlated with completion, non-completion and cycling between completion and non-completion among clients admitted to Alberta Residential Withdrawal Management Services.
methodsThe study included data on clients from a provincial database (N = 20,020) admitted to residential withdrawal management units across Alberta between April 1, 2015, and March 31, 2022. We collapsed admission-level data into client-level data, where each individual's information is captured as a unique record. Multinomial logistic regression was performed to investigate correlates of completion, non-completion, and multiple cycles of completion and non-completion. Clients in these three categories were compared in their socio-demographics, primary substance of concern, and other program variables of admission count, length of stay, transition to treatment, facilities utilized, days of discharge, and years of admission.
resultsThe study sample included 39,952 admissions, with an average of two per client. Overall, 55.8% (n = 11,170) of discharged clients completed the program, 25.5% (n = 5,106) were non-completed, and 18.7% (n = 3,744) cycled between completion and non-completion. Regression analysis indicated that clients who used a single substance, primarily alcohol, cocaine and marijuana, completed post-secondary education, were employed or had unstable employment, and were married had lower odds of non-completion. Other variables related to higher odds of completion were urban residence, multiple admissions to a facility, and longer lengths of stay. Conversely, clients who primarily used amphetamines, barbiturates, crystal meth, opiates, and tranquillizers had higher odds of non-completion. Female gender, being discharged on Saturday and Sunday, using detoxification as a standalone service without transitioning to residential treatment and admission to two or more facilities also correlated with higher odds of non-completion.
conclusionResults indicated that the type of substances, gender, education, marital status, employment, place of residence, and transition to residential services were associated with detoxication outcomes. These findings can inform the customization and allocation of services, targeted support, service intensity and areas requiring additional attention and investment to improve treatment outcomes.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.